Dimethylfraxetin |
A coumarin with anti-inflammatory activity; reduces TPA-induced auricular… |
5 mg |
36485-5 |
More Info
|
Dimethyl fumarate |
A lipophilic electrophile that has profound effects on oxidative and immun… |
100 g |
14714-100 |
More Info
|
Dimethyl fumarate |
A lipophilic electrophile that has profound effects on oxidative and immun… |
25 g |
14714-25 |
More Info
|
Dimethyl fumarate |
A lipophilic electrophile that has profound effects on oxidative and immun… |
250 g |
14714-250 |
More Info
|
Dimethyl fumarate |
A lipophilic electrophile that has profound effects on oxidative and immun… |
50 g |
14714-50 |
More Info
|
Dimethyl 2-ketoglutarate |
An esterified form of α-ketoglutarate; increases intracellular level… |
1 g |
28394-1 |
More Info
|
Dimethyl 2-ketoglutarate |
An esterified form of α-ketoglutarate; increases intracellular level… |
5 g |
28394-5 |
More Info
|
Dimethyl 2-ketoglutarate |
An esterified form of α-ketoglutarate; increases intracellular level… |
500 mg |
28394-500 |
More Info
|
2,3-Dimethylmethcathinone (hydrochloride) |
A potential designer drug that is structurally related to 4-MMC; intended… |
10 mg |
11225-10 |
More Info
|
2,3-Dimethylmethcathinone (hydrochloride) |
A potential designer drug that is structurally related to 4-MMC; intended… |
5 mg |
11225-5 |
More Info
|
2,3-Dimethylmethcathinone (hydrochloride) |
A potential designer drug that is structurally related to 4-MMC; intended… |
50 mg |
11225-50 |
More Info
|
2,4-Dimethylmethcathinone (hydrochloride) |
A disubstituted analog of methcathinone; intended for research and forensi… |
10 mg |
11243-10 |
More Info
|
2,4-Dimethylmethcathinone (hydrochloride) |
A disubstituted analog of methcathinone; intended for research and forensi… |
5 mg |
11243-5 |
More Info
|
2,4-Dimethylmethcathinone (hydrochloride) |
A disubstituted analog of methcathinone; intended for research and forensi… |
50 mg |
11243-50 |
More Info
|
3,4-Dimethylmethcathinone (hydrochloride) |
A potential designer drug that is structurally related to 4-MMC; intended… |
10 mg |
9001098-10 |
More Info
|
3,4-Dimethylmethcathinone (hydrochloride) |
A potential designer drug that is structurally related to 4-MMC; intended… |
25 mg |
9001098-25 |
More Info
|
3,4-Dimethylmethcathinone (hydrochloride) |
A potential designer drug that is structurally related to 4-MMC; intended… |
5 mg |
9001098-5 |
More Info
|
3,4-Dimethylmethcathinone metabolite (hydrochloride) ((±)-Pseudoephedrine stereochemistry) |
A metabolite of 3,4-dimethylmethcathinone that features conversion of the… |
1 mg |
9001437-1 |
More Info
|
3,4-Dimethylmethcathinone metabolite (hydrochloride) ((±)-Pseudoephedrine stereochemistry) |
A metabolite of 3,4-dimethylmethcathinone that features conversion of the… |
5 mg |
9001437-5 |
More Info
|
3,4-Dimethylmethcathinone metabolite (hydrochloride) ((±)-Pseudoephedrine stereochemistry) |
A metabolite of 3,4-dimethylmethcathinone that features conversion of the… |
500 µg |
9001437-500 |
More Info
|
3-(2,3-Dimethylphenyl)-2-methyl-4(3H)-quinazolinone |
An analytical reference standard categorized as a quinazolinone; intended… |
1 mg |
34174-1 |
More Info
|
3-(2,3-Dimethylphenyl)-2-methyl-4(3H)-quinazolinone |
An analytical reference standard categorized as a quinazolinone; intended… |
5 mg |
34174-5 |
More Info
|
1-(3,5-Dimethylphenyl)piperazine |
A piperidine compound that is inactive at dopamine and serotonin receptors… |
1 g |
20627-1 |
More Info
|
1-(3,5-Dimethylphenyl)piperazine |
A piperidine compound that is inactive at dopamine and serotonin receptors… |
250 mg |
20627-250 |
More Info
|
1-(3,5-Dimethylphenyl)piperazine |
A piperidine compound that is inactive at dopamine and serotonin receptors… |
500 mg |
20627-500 |
More Info
|
3,5-dimethyl PIT-1 |
A selective nonphosphoinositide inhibitor with favorable solubility in viv… |
1 mg |
10727-1 |
More Info
|
3,5-dimethyl PIT-1 |
A selective nonphosphoinositide inhibitor with favorable solubility in viv… |
10 mg |
10727-10 |
More Info
|
3,5-dimethyl PIT-1 |
A selective nonphosphoinositide inhibitor with favorable solubility in viv… |
25 mg |
10727-25 |
More Info
|
3,5-dimethyl PIT-1 |
A selective nonphosphoinositide inhibitor with favorable solubility in viv… |
5 mg |
10727-5 |
More Info
|
16,16-dimethyl Prostaglandin A1 |
An inhibitor of HSV and HIV-1 viral replication; a metabolism resistant an… |
1 mg |
10080-1 |
More Info
|
16,16-dimethyl Prostaglandin A1 |
An inhibitor of HSV and HIV-1 viral replication; a metabolism resistant an… |
10 mg |
10080-10 |
More Info
|
16,16-dimethyl Prostaglandin A1 |
An inhibitor of HSV and HIV-1 viral replication; a metabolism resistant an… |
5 mg |
10080-5 |
More Info
|
16,16-dimethyl Prostaglandin A2 |
16,16-dimethyl PGA2 is a metabolism resistant analog of PGA2 with a prolon… |
1 mg |
10280-1 |
More Info
|
16,16-dimethyl Prostaglandin A2 |
16,16-dimethyl PGA2 is a metabolism resistant analog of PGA2 with a prolon… |
10 mg |
10280-10 |
More Info
|
16,16-dimethyl Prostaglandin A2 |
16,16-dimethyl PGA2 is a metabolism resistant analog of PGA2 with a prolon… |
5 mg |
10280-5 |
More Info
|
16,16-dimethyl Prostaglandin D2 |
16,16-dimethyl PGD2 is a metabolically stable synthetic analog of PGD2. It… |
1 mg |
12750-1 |
More Info
|
16,16-dimethyl Prostaglandin D2 |
16,16-dimethyl PGD2 is a metabolically stable synthetic analog of PGD2. It… |
10 mg |
12750-10 |
More Info
|
16,16-dimethyl Prostaglandin D2 |
16,16-dimethyl PGD2 is a metabolically stable synthetic analog of PGD2. It… |
5 mg |
12750-5 |
More Info
|
16,16-dimethyl Prostaglandin D2 |
16,16-dimethyl PGD2 is a metabolically stable synthetic analog of PGD2. It… |
500 µg |
12750-500 |
More Info
|
16,16-dimethyl Prostaglandin E1 |
16,16-dimethyl PGE1 is a metabolically stable synthetic analog of PGE1. It… |
1 mg |
13750-1 |
More Info
|
16,16-dimethyl Prostaglandin E1 |
16,16-dimethyl PGE1 is a metabolically stable synthetic analog of PGE1. It… |
10 mg |
13750-10 |
More Info
|
16,16-dimethyl Prostaglandin E1 |
16,16-dimethyl PGE1 is a metabolically stable synthetic analog of PGE1. It… |
5 mg |
13750-5 |
More Info
|
16,16-dimethyl Prostaglandin E2 |
A competitive inhibitor of 15-hydroxy PGDH; acts as an agonist on most EP… |
1 mg |
14750-1 |
More Info
|
16,16-dimethyl Prostaglandin E2 |
A competitive inhibitor of 15-hydroxy PGDH; acts as an agonist on most EP… |
10 mg |
14750-10 |
More Info
|
16,16-dimethyl Prostaglandin E2 |
A competitive inhibitor of 15-hydroxy PGDH; acts as an agonist on most EP… |
5 mg |
14750-5 |
More Info
|
16,16-dimethyl Prostaglandin E2 p-(p-acetamidobenzamido) phenyl ester |
The p-(p-acetamidobenzamido) phenyl ester is a crystalline derivative of 1… |
1 mg |
14753-1 |
More Info
|
16,16-dimethyl Prostaglandin E2 p-(p-acetamidobenzamido) phenyl ester |
The p-(p-acetamidobenzamido) phenyl ester is a crystalline derivative of 1… |
10 mg |
14753-10 |
More Info
|
16,16-dimethyl Prostaglandin E2 p-(p-acetamidobenzamido) phenyl ester |
The p-(p-acetamidobenzamido) phenyl ester is a crystalline derivative of 1… |
5 mg |
14753-5 |
More Info
|
16,16-dimethyl Prostaglandin E2 p-(p-acetamidobenzamido) phenyl ester |
The p-(p-acetamidobenzamido) phenyl ester is a crystalline derivative of 1… |
500 µg |
14753-500 |
More Info
|
16,16-dimethyl Prostaglandin F2α |
16,16-dimethyl PGF2α is a metabolically stable analog of PGF2α… |
1 mg |
16750-1 |
More Info
|